The authors found that MMP-1, MMP-7 and MMP-9 serum levels were slightly elevated in NSCLC patients, prompting the team to rely on larger cohorts for the evaluation of these MMPs as biomarkers for NSCLC. The gene discussed is MMP9; the disease is non-small cell lung carcinoma.